HYALURONAN - RELATIONSHIP TO HEMODYNAMICS AND SURVIVAL IN PORCINE INJURY AND SEPSIS

被引:22
作者
BERG, S
JANSSON, I
HESSELVIK, FJ
LAURENT, TC
LENNQUIST, S
WALTHER, S
机构
[1] LINKOPING UNIV HOSP, DEPT SURG, S-58185 LINKOPING, SWEDEN
[2] UNIV UPPSALA, DEPT MED & PHYSIOL CHEM, S-75105 UPPSALA, SWEDEN
关键词
HEMODYNAMICS; HYALURONIC ACID; LIVER; LIVER CIRCULATION; SEPTICEMIA; SEPTIC SHOCK; STAPHYLOCOCCUS-AUREUS; SURVIVAL; WOUNDS; INJURIES; TRAUMA;
D O I
10.1097/00003246-199209000-00020
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background and Methods: Hyaluronan is a polysaccharide normally present in low concentrations in the blood, and is rapidly cleared from the blood by the liver. Increased plasma hyaluronan concentrations have been found in patients with sepsis. We studied changes in serum hyaluronan concentrations and their relationship to hemodynamics and survival in a 48-hr porcine model of injury and sepsis. Results: Circulating hyaluronan concentrations increased to high values after induction of experimental sepsis (from mean baseline values of 242 +/- 26 [SEM] to mean maximum concentrations of 964 +/- 255-mu-g/L [p <.01]) compared with controls (199 +/- 38 to 303 +/- 32-mu-g/L). A weak negative correlation between mean arterial pressure (MAP) and serum hyaluronan values was found (r2 = .47; p < .01). Nonsurvivors had higher mean serum hyaluronan concentrations than survivors (603 +/- 147 vs. 285 +/- 43-mu-g/L [p < .05]). Conclusions: Experimental sepsis is associated with an increase in serum hyaluronan values. The relationship between decreased MAP and increased serum hyaluronan concentrations could point to reduced liver perfusion as a cause. An association between high hyaluronan values and nonsurvival in sepsis is possible.
引用
收藏
页码:1315 / 1321
页数:7
相关论文
共 21 条
  • [1] ARVIDSSON D, 1991, SURGERY, V109, P190
  • [2] ELEVATED LEVELS OF PLASMA HYALURONAN IN SEPTICEMIA
    BERG, S
    BRODIN, B
    HESSELVIK, F
    LAURENT, TC
    MALLER, R
    [J]. SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1988, 48 (08) : 727 - 732
  • [3] BRANDT R, 1987, ACTA OTO-LARYNGOL, P31
  • [4] DAHN MS, 1990, ARCH SURG-CHICAGO, V125, P441
  • [5] INCREASED SERUM LEVELS OF HYALURONATE IN LIVER-DISEASE
    ENGSTROMLAURENT, A
    LOOF, L
    NYBERG, A
    SCHRODER, T
    [J]. HEPATOLOGY, 1985, 5 (04) : 638 - 642
  • [6] CONCENTRATION OF SODIUM HYALURONATE IN SERUM
    ENGSTROMLAURENT, A
    LAURENT, UBG
    LILJA, K
    LAURENT, TC
    [J]. SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1985, 45 (06) : 497 - 504
  • [7] ELIMINATION OF HYALURONIC-ACID FROM THE BLOOD STREAM IN THE HUMAN
    FRASER, JRE
    LAURENT, TC
    ENGSTROMLAURENT, A
    LAURENT, UGB
    [J]. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1984, 11 (01) : 17 - 25
  • [8] FRASER JRE, 1989, BIOL HYALURONAN, V143, P41
  • [9] HAMERMAN D, 1984, P SOC EXP BIOL MED, V177, P205
  • [10] LAURENT TC, 1987, ACTA OTO-LARYNGOL, P7